Delivery Order SPE2DB24D3015-SPE2DB25FGAMV
- Not listed
- The Defense Logistics Agency awarded a $2,106.02 delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on September 3, 2025, with an ultimate completion date of September 24, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $157,944 for Varivax vaccine with diluents on June 18, 2025, with an ultimate completion date of July 11, 2025. This firm fixed price contract, which is not set-aside, will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger prime indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $19,808.64 delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on August 13, 2025, with an ultimate completion date of September 4, 2025. This is a firm fixed-price, non-set-aside contract issued under a child delivery order structure. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order derives from AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,106.02 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on September 11, 2025, with an ultimate completion date of October 2, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on July 29, 2025, with a ceiling value of $2,106.02 and an ultimate completion date of August 19, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support...
- The Defense Logistics Agency awarded a $46,444.95 delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on August 29, 2025, with an ultimate completion date of September 22, 2025. This firm fixed price contract was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $3,159.03 delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on August 28, 2025, with a completion date of September 19, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed in Conshohocken, Pennsylvania, where the contractor maintains its corporate headquarters. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on September 8, 2025, with a ceiling value of $1,032.11 and an ultimate completion date of September 29, 2025. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999.99 billion and extends through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,053.01 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with an ultimate completion date of September 11, 2025. This competitive award, issued on August 20, 2025, represents a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on June 2, 2025, with a ceiling value of $3,159.03 and an ultimate completion date of June 24, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA...
- SPE2DB24D3015Indefinite Delivery Contract
- SPE2DB24D3015-SPE2DB25FGAMVDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for Varivax vaccine with diluents, valued at $2,106.02 with a completion date of September 3, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 global pharmaceutical support vehicle through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates significant capability in delivering a comprehensive range of pharmaceutical products including vaccines, specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. The delivery order for Varivax vaccine reflects AmerisourceBergen's ongoing role as a primary vendor within DLA's medical supply chain, contributing to vaccine availability for military and federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/12/25 |